Oxford Biodynamics PLC

OXFORD, X0 · CIK 0001892722 · Medtech · Public

EpiSwitch diagnostic platform that measures epigenetic biomarkers from blood samples

oxfordbiodynamics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.0M
1 Form D · Nov 2021
59 months since last filing
Contracts
—
No federal contracts on record
Patents
24
11 granted · 13 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1446Clear Advantage Collar, Inc.—$360K
1447Obstetrx, Inc.—$1.1M
1448Anuncia Medical, Inc.—$12M
1449Oxford Biodynamics PLC—$5.0M
1450EUTROPICS PHARMACEUTICALS, INC.—$350K
1451CELLOGY, INC.——
1452SOSTOS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Alexandre AkoulitchevDirector
  • Jon BurrowsDirector · Executive Officer
  • Stephen DiggleDirector
  • David HolbrookDirector
  • Paul StockdaleDirector · Executive Officer
  • Matthew WakefieldDirector

Patents

USPTO · 11 granted of 24

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.